J 2020

Typy a příprava lipozomálních přípravků pro plicní podání

HOŘAVOVÁ, Hana, Jan GAJDZIOK and David VETCHÝ

Basic information

Original name

Typy a příprava lipozomálních přípravků pro plicní podání

Name (in English)

Types and Preparation of Liposomal Formulations for Pulmonary Administration

Authors

HOŘAVOVÁ, Hana (203 Czech Republic, belonging to the institution), Jan GAJDZIOK (203 Czech Republic, belonging to the institution) and David VETCHÝ (203 Czech Republic, belonging to the institution)

Edition

CHEMICKÉ LISTY, Praha, Česká společnost chemická, 2020, 0009-2770

Other information

Language

Czech

Type of outcome

Článek v odborném periodiku

Field of Study

30104 Pharmacology and pharmacy

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 0.381

RIV identification code

RIV/00216224:14160/20:00118116

Organization unit

Faculty of Pharmacy

UT WoS

000531098900002

Keywords in English

liposomes; lung application; spray drying; lyophylization; dry powder formulations; protectants

Tags

Tags

International impact, Reviewed
Změněno: 26/2/2021 11:17, Mgr. Hana Hurtová

Abstract

V originále

The use of liposomes as carriers for different types of drugs in formulations to be administered to the lungs brings a number of advantages, including the possibility of controlled release, prolongation of retention at the site of action or reduced systemic exposure. However, the main disadvantage of liposomal suspensions is their physical and chemical instability. Therefore, they are preferably converted to dry powders by several drying technologies. In doing so, it is necessary to include specific excipients in the formulation, in particular protectants (saccharides), protecting liposomes from changes during these processes.

In English

The use of liposomes as carriers for different types of drugs in formulations to be administered to the lungs brings a number of advantages, including the possibility of controlled release, prolongation of retention at the site of action or reduced systemic exposure. However, the main disadvantage of liposomal suspensions is their physical and chemical instability. Therefore, they are preferably converted to dry powders by several drying technologies. In doing so, it is necessary to include specific excipients in the formulation, in particular protectants (saccharides), protecting liposomes from changes during these processes.